Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor necrosis factor receptor superfamily member 1B (TNFR2) is a receptor for tumor necrosis factor-alpha (TNFα), a key cytokine in inflammation and immune regulation. Unlike TNFR1, TNFR2 expression is restricted and primarily found on immune cell subsets. TNFR2 lacks a death domain and signals through TRAF proteins to activate NFκB pathways, promoting cell survival and proliferation. TNFR2 plays complex roles in cancer, acting both pro-tumorigenically by supporting immunosuppressive cells and anti-tumorigenically by activating cytotoxic T-cells. It is also implicated in neuroprotection.
Agonism or antagonism of TNFR2 signaling pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Necrosis Factor Receptor Superfamily Member 1B (TNFR2).